Given that SMAD4 is an identified miR-301a target in multiple cancers, including lung,24 prostate,21 and pancreatic cancers,25 the present study investigated whether SMAD4 was upregulated in fibroblasts with miR-301a inhibition. Here, SMAD4 is linked to familial pancreatic carcinoma.